Latest news with #Brainbees
Business Upturn
5 days ago
- Business
- Business Upturn
Brainbees Solutions shares surge 15% on heavy trading volume
Shares of Brainbees Solutions witnessed a significant upswing in Tuesday's trading session, jumping 15% amid strong investor interest. As of 1:41 PM, the shares were trading 14.05% higher at Rs 389.20. The stock opened at ₹341.25 and climbed to an intraday high of ₹392.90 before settling within the day's range of ₹340.05 to ₹392.90. Despite today's rally, the stock remains well below its 52-week high of ₹734.00. However, it has rebounded considerably from its 52-week low of ₹286.05, marking a positive short-term trend. Brainbees Solutions Q4 Results Brainbees Solutions, the parent company of FirstCry, reported a robust 15.84% year-on-year increase in revenue, reaching ₹1,930 crore for the latest financial period, up from ₹1,666 crore the previous year. Despite this top-line growth, profitability metrics took a significant hit. The company's EBITDA dropped by 51.51%, falling to ₹16 crore from ₹33 crore a year earlier. As a result, the EBITDA margin shrank by 115 basis points, landing at 0.82% compared to the previous 1.98%. Adding to the concerns, Brainbees reported a net loss of ₹76.7 crore, deepening from the ₹51.7 crore loss in the same period last year. The financials also revealed an exceptional loss of ₹36.7 crore this quarter, contributing further to the bottom-line decline. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Reuters
27-05-2025
- Business
- Reuters
India's equity benchmarks to open little changed
May 27 (Reuters) - India's benchmark indexes are likely to open little changed on Tuesday, following the previous session's gains on easing trade tensions between the U.S. and the European Union. Gift Nifty futures were trading at 25,027.5 as of 8:08 a.m. IST, indicating that the Nifty 50 (.NSEI), opens new tab will open near its Monday's close of 25,001.15. MSCI Asia ex-Japan (.MIAPJ0000PUS), opens new tab dipped 0.2%, after being largely steady on Monday as U.S. President Donald Trump delayed imposing tariffs on EU goods on June 1, restoring a July 9 deadline. The EU said Trump's decision gave new impetus to trade talks. U.S. markets were closed on Monday for a holiday, while global stock markets climbed. Back home, the early onset of monsoon rains and Reserve Bank of India's record dividend transfer to the government also aided sentiment, although the dividend was below analysts' estimates. Both foreign portfolio investors (FPIs) and domestic institutional investors (DIIs) were buyers on Monday. While DIIs bought shares worth 17.46 billion rupees ($205.2 million), FPIs bought stocks worth $16 million, according to provisional data. ** IndiGo ( opens new tab will be in focus as media report says co-founder Rakesh Gangwal will sell up to a 3.4% stake through a block deal worth nearly $803 million ** FirstCry parent Brainbees Solutions ( opens new tab posts a wider fourth-quarter loss at 767.4 milion rupees even as its revenue rose about 16% ** Aurobindo Pharma ( opens new tab posts flat profit from last year as its margins drop while revenue increases. The pharmaceutical company says it plans for first U.S. Food and Drug Administration submission in FY2026
Economic Times
27-05-2025
- Business
- Economic Times
Brainbees Solutions shares in focus after Q4 net loss widens to Rs 111 crore YoY
For the full year, however, Brainbees trimmed its net loss to Rs 265 crore from Rs 322 crore in FY24. Brainbees Solutions, FirstCry's parent firm, reported a Q4 net loss of Rs 111 crore, up from Rs 43 crore in the year-ago period. Revenue rose 16% YoY to Rs 1,930 crore. Despite quarterly setbacks, the company trimmed its annual loss and posted a 43% rise in adjusted EBITDA for the full FY25. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Brainbees Solutions share price target Brainbees Solutions shares performance Shares of Brainbees Solutions , the parent company of FirstCry , will be in focus on Tuesday after the firm reported a net loss of Rs 111 crore for Q4FY25, widening from Rs 43 crore in the year-ago period. Revenue from operations rose 16% year-on-year to Rs 1,930 crore, up from Rs 1,667 crore in a sequential basis, the net loss also widened, compared to a loss of Rs 15 crore in Q3FY25. Revenue declined 11% quarter-on-quarter from Rs 2,172 crore in the preceding three the full year, however, Brainbees trimmed its net loss to Rs 265 crore from Rs 322 crore in FY24. Annual revenue rose 18% to Rs 7,660 crore, while adjusted EBITDA surged 43% year-on-year to Rs 394 crore. Cash profit after tax nearly doubled to Rs 209 crore, up 96%.The gross profits in Q4FY25 were up at Rs 1,206 crore versus Rs 1,055 crore in Q4FY24, while the gross profit margin in the respective quarters stood at 37.5% and 36.7%.The adjusted Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) stood at Rs 100 crore in the quarter under review, up from Rs 84 crore in the year ago company said that 38% of GMV generated by top 20 cities in FY25 is from cross-channel customers (transacting both online & offline).According to Trendlyne, the average target price for Brainbees Solutions is Rs 528, indicating a potential upside of nearly 41% from current levels. Of the seven analysts tracking the stock, the consensus rating is 'Buy'.Shares of Brainbees Solutions closed at Rs 375 on Monday, up 0.47% on the BSE, while the Sensex gained 0.56%. The stock is down 42% year-to-date but has risen 11% in the past month. The company's market capitalisation currently stands at Rs 19,563 crore.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Time of India
27-05-2025
- Business
- Time of India
Brainbees Solutions shares in focus after Q4 net loss widens to Rs 111 crore YoY
Shares of Brainbees Solutions , the parent company of FirstCry , will be in focus on Tuesday after the firm reported a net loss of Rs 111 crore for Q4FY25, widening from Rs 43 crore in the year-ago period. Revenue from operations rose 16% year-on-year to Rs 1,930 crore, up from Rs 1,667 crore in Q4FY24. On a sequential basis, the net loss also widened, compared to a loss of Rs 15 crore in Q3FY25. Revenue declined 11% quarter-on-quarter from Rs 2,172 crore in the preceding three months. For the full year, however, Brainbees trimmed its net loss to Rs 265 crore from Rs 322 crore in FY24. Annual revenue rose 18% to Rs 7,660 crore, while adjusted EBITDA surged 43% year-on-year to Rs 394 crore. Cash profit after tax nearly doubled to Rs 209 crore, up 96%. Also Read: High conviction picks! ICICI Bank, HAL among 10 large-cap stock ideas from PL Capital The gross profits in Q4FY25 were up at Rs 1,206 crore versus Rs 1,055 crore in Q4FY24, while the gross profit margin in the respective quarters stood at 37.5% and 36.7%. The adjusted Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) stood at Rs 100 crore in the quarter under review, up from Rs 84 crore in the year ago period. The company said that 38% of GMV generated by top 20 cities in FY25 is from cross-channel customers (transacting both online & offline). Brainbees Solutions share price target According to Trendlyne, the average target price for Brainbees Solutions is Rs 528, indicating a potential upside of nearly 41% from current levels. Of the seven analysts tracking the stock, the consensus rating is 'Buy'. Brainbees Solutions shares performance Shares of Brainbees Solutions closed at Rs 375 on Monday, up 0.47% on the BSE, while the Sensex gained 0.56%. The stock is down 42% year-to-date but has risen 11% in the past month. The company's market capitalisation currently stands at Rs 19,563 crore. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) ETMarkets WhatsApp channel )
Business Upturn
27-05-2025
- Business
- Business Upturn
Stocks to watch on May 27: CLSA, HSBC, Jefferies issue fresh views on Glenmark, Fusion, Nazara, AB Fashion, IT sector
A series of post-earnings commentary from top brokerages have spotlighted key stocks including Glenmark Pharma, Fusion Microfinance, Nazara Technologies, Brainbees (FirstCry), and Aditya Birla Fashion, among others. CLSA on Fusion Microfinance: Underperform, TP ₹155 CLSA maintained an underperform rating on Fusion Fin, citing limited forward guidance from the management, which includes a newly appointed CEO. The brokerage noted that disbursement trends for Q1FY26 are expected to remain similar to Q4 levels. While the company has maintained a high provision coverage ratio (PCR) of 96.5% on its Stage 3 pool (7.9% of AUM), net slippages in the past two quarters were higher at 13–14% annualised, compared to CA Grameen's 11%. Write-offs were nearly three times those of CA Grameen. CLSA is currently building in 7% AUM growth and a 6% credit cost for FY26, but sees comfort in the company's successful rights issue. Morgan Stanley on Brainbees (FirstCry): Overweight, TP ₹574 Morgan Stanley retained its overweight stance on Brainbees following a solid Q4 showing. GMV rose 14% YoY, while revenue and adjusted EBITDA (excluding share-based expenses) grew by 16% and 20% YoY, respectively. For the first time, the company disclosed that apparel and footwear accounted for 52% of India multichannel GMV in FY25. Meanwhile, the share of homegrown brands rose to 55%, compared to 37% in FY20. Despite a revenue miss across segments, the core Brainbees business stood out. HSBC on Glenmark Pharma: Buy, TP ₹1,720 HSBC maintained a buy rating on Glenmark Pharma despite a weak Q4, which included operational misses and one-offs that dragged reported profit. However, the brokerage believes that the India and US businesses — which contribute a combined 56% of FY25 revenue — have likely bottomed out. HSBC highlighted that a potential outlicensing deal for the investigational drug ISB 2001 remains a key catalyst for a valuation re-rating. HSBC on IT sector: Mixed outlook HSBC noted that Indian IT firms have seen a drop in cash conversion metrics during FY25, with mid-tier companies underperforming their larger counterparts. While market valuations still favour topline growth, HSBC pointed to rising investor focus on earnings quality. TCS saw a gradual decline in conversion, while Coforge and Persistent Systems remained the weakest. Jefferies on AB Fashion: Buy, TP ₹100 Jefferies reiterated a buy call on Aditya Birla Fashion, noting a well-rounded Q4 performance. The brokerage cited strong margin expansion in Pantaloons, a significant reduction in losses from TMRW, over 40% growth in the ethnic wear segment (excluding TCNS), and healthy same-store sales across lifestyle brands. However, the net cash position came in below estimates. CLSA on Nazara Technologies: Underperform, TP ₹705 CLSA remained cautious on Nazara after the gaming and e-sports company missed Q4 estimates. Revenue and EBITDA fell 3% sequentially. While FY25 revenue surged 43% YoY to ₹16.2 billion, margins declined by 179 basis points to 9.4%. The brokerage cut FY26–27 revenue and profit estimates by 2–9%, factoring in continued pressure and excluding the pending Curves Games acquisition. Nazara's e-sports revenue rose 21% YoY, while its real-money gaming associate PokerBaazi posted a 39% YoY rise in revenue, but remained loss-making. Disclaimer: This report is for informational purposes only. Business Upturn does not offer investment advice or stock recommendations. Readers are advised to consult a certified financial advisor before making any financial decisions. News desk at
